Company Filing History:
9 out of 123 
3 out of 755 
3 out of 3 
Years Active: 1977-2018
Title: John L. Neumeyer: Innovator in Aporphine Derivatives and Their Medical Applications
Introduction: John L. Neumeyer, based in Wayland, MA, is a distinguished inventor recognized for his significant contributions to the field of medicinal chemistry. With 20 patents to his name, Neumeyer has focused his innovative efforts on developing compounds that hold potential for treating a range of neurological and psychological disorders.
Latest Patents: Among his latest inventions are the patents for 2-alkoxy-11-hydroxyaporphine derivatives. These groundbreaking compounds selectively bind to D-receptors, making them valuable for both imaging D-receptors and treating diseases such as Parkinson's disease, sexual dysfunction, and depressive disorders. This work highlights Neumeyer's commitment to addressing critical health challenges through innovation.
Career Highlights: Neumeyer has had a notable career with significant affiliations, including roles at the McLean Hospital Corporation and Northeastern University. His work in these institutions has facilitated the research and development of his patented inventions, allowing him to contribute meaningful advancements in medical science.
Collaborations: Throughout his career, Neumeyer has collaborated with other prominent figures in the field, including Richard A. Milius and Robert B. Innis. These partnerships have enriched his research endeavors and led to the successful development of valuable medical compounds.
Conclusion: John L. Neumeyer's innovative spirit and dedication to advancing medicinal chemistry have established him as a valuable contributor to the scientific community. His work on 2-alkoxy-11-hydroxyaporphine derivatives reflects his commitment to improving healthcare through targeted interventions. As his research progresses, the potential impact of his inventions on treating various diseases continues to grow.